Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Kidney Int. 2014 Jan 15;85(5):1214–1224. doi: 10.1038/ki.2013.497

Figure 4.

Figure 4

Logistic regression analysis of the effect of the plasma concentration of proteogenic amino acids and amino acid derivatives on the risk of progression to ESRD in subjects with T2D.

Footnote: Data are odds ratios and 95% confidence intervals (OR, 95% CI) estimated for an effect of one standard deviation change of the metabolite. * Metabolite was not stable over time but is shown for its biological relevance. Abbreviations: ESRD – end stage renal disease, T2D – type 2 diabetes,HbA1c – hemoglobin A1c, AER – albumin excretion rate, eGFR – estimated glomerular filtration rate, OR – odds ratio.

HHS Vulnerability Disclosure